Effect of an angiotensin receptor antagonist on cerebral blood flow, cerebral perfusion pressure, and systemic and peripheral haemodynamics in patients with acute stroke "TAST"


Phase N/A Results N/A

Summary of Purpose

To lower blood pressure in hypertensive patients with acute stroke using telmisartan (an angiotensin receptor antangonist) without reducing cerebral blood flow.

Read More →

Trial Milestones

The following dates are available for this trial. Trial information last updated on 28 April 2009.

Unavailable Unavailable Unavailable Unavailable Unavailable Unavailable
Start Date First Received 1st Completion Completion Verification Results

Trial Basics



  • British Heart Foundation University of Nottinghoam

Trial Design

Single centre, interventional, randomised, double blind placebo controlled trial.


  • University of Nottingham (UK) Research Innovation Department University of Nottingham Kings Meadow Campus Nottingham NG7 2NR United Kingdom Tel +44 (0)115 9515792 Fax +44 (0)115 9515796 Email paul.cartledge@nottingham.ac.uk